Skip to main content

Garvan Institute - Transient production of SARS-COV-2 antigen (spike protein)

Project Member(s): Ralph, P.

Funding or Partner Organisation: Garvan Institute of Medical Research
Garvan Institute of Medical Research

Start year: 2020

Summary: To express SARS-COV-2 spike proteins transiently in HEK-293 cells using Expi293 expression platform from Thermo

FOR Codes: Human Pharmaceutical Treatments (e.g. Antibiotics), Medical Molecular Engineering of Nucleic Acids and Proteins, Human pharmaceutical treatments